Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06730997

Clinicopathological Features of Renal Cell Carcinoma in Young Patients

Analysis of Clinicopathologic Characters of Renal Cell Carcinoma in Young Patients and their influence on the survival outcomes

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

About this study

Worldwide, RCC accounts for 2-3% of All adult malignancies and the 8th most commonly diagnosed primary cancer among all adults.

Representing 3rd place among urinary system tumors. Most of RCC occurs in old age while about 7% occurs in younger adults below 40 years.

Recently the published data about the tumor Clinco-pathological features, treatment response and outcomes were different in young adults than older patients, where some data showed favorable features and survivals, while other showed negative ones.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age < 40 years
  • Patients proven to have RCC
  • Patients eligible to receive treatment

Exclusion criteria

  • Second malignancy.

Treatment and study plan

Primary outcomes

  1. Analysis of Clinicopathologic Characters of Renal Cell Carcinoma in Young Patients and their influence on the survival outcomes

    Time frame: Analysis of Clinicopathologic Characters of Renal Cell Carcinoma in Young Patient in period from 2010 -2024

    Analysis of Clinicopathologic Characters of Renal Cell Carcinoma in Young Patients and their influence on the survival outcomes

Study contacts

Contact information is provided by the study sponsor or research team.

Dina Gamal Abdelaziz

CONTACT

[email protected]

01147625820

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Clinicopathological Features of Renal Cell Carcinoma in Young Patients and it's Influence on the Survival Outcome

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
Dec 12, 2024
Registry last updated
Dec 12, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.